Insights and updates

Braskem reviews Ordinary EBITDA of R$2.4 billion in 3Q24, 44% upper in comparison to 2Q24

[ad_1]

Absolute best quarterly Ordinary EBITDA since 2Q22

SÃO PAULO, Nov. 7, 2024 /PRNewswire/ —  BRASKEM S.A. (B3: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK), the most important resin manufacturer within the Americas and the sector’s biopolymers manufacturer, items its 3Q24 Income Shed.

3Q24 HIGHLIGHTS 

CONSOLIDATED

  • Ordinary EBITDA of US$432 million, about 35% upper than in 2Q24 and 130% upper than in 3Q23.
  • Money place of US$2.4 billion, making sure protection of debt maturities over the upcoming 52 months.
  • Working Money Time of US$75 million, round R$416 million, upper than 2Q24.

The total profits let fall is to be had at the Corporate’s IR web site: www.braskem-ri.com.br/en

Braskem will host convention screams to speak about its Effects Thursday, November 7 at 09:00 a.m. US ET.

Spare knowledge is also bought from the Investor Family members Section at +55 11 3576-9531 or [email protected].

SOURCE Braskem S.A.

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3

440k+
Newsrooms &
Influencers

icon1

9k+
Virtual Media
Retailers

icon2

270k+
Reporters
Opted In

[ad_2]

Source link